Arcview Collective Fund

The fund draws its pipeline from the Arcview investor network's proprietary screening process, which reviews over 400 deals per year through live summits, expert panels, and structured due-diligence sessions where members evaluate and score presenting companies alongside the investment team.

It operates as a pooled-investment vehicle that sits atop the Arcview membership network. Unlike a traditional VC firm with a closed general-partner structure, the fund's deal access was historically driven by a paid membership community that participated in evaluation, making it a hybrid between a managed fund and a member-driven syndicate.

The fund invests across the cannabis supply chain, including plant-touching operators in cultivation and branded products, as well as ancillary companies providing technology, compliance, and infrastructure services to the industry. Its mandate spans early-stage through growth-stage rounds, typically as equity co-investments alongside Arcview network members.

Co-founders Troy Dayton and Steve DeAngelo shaped the fund's investment thesis and maintained significant influence over the screening pipeline. Specific day-to-day fund managers and any internal investment committee members beyond the co-founders have not been publicly detailed.

The Arcview ecosystem reported facilitating over $400 million in aggregate capital deployment across its network since inception, as of late 2023. The Collective Fund's specific AUM remains undisclosed and is a subset of that total figure.